臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

	English \| 正體中文 \| 简体中文 \| 總筆數 :0
	造訪人次 : 53286670 線上人數 : 906 教育部委託研究計畫計畫執行:國立臺灣大學圖書館

搜尋範圍

進階搜尋

登入

管理

臺灣學術機構典藏系統 (Taiwan Academic Institutional Repository, TAIR)

關於TAIR
	計畫說明

瀏覽
	典藏機構
	作者
	題名
	日期
	統計圖表
	機構即時統計
	學術趨勢

消息
	2019臺灣學術機構典藏研討會
	機構典藏系統RC7版本已發佈

著作權
	出版社及期刊政策查詢
	TAIR著作權會議記錄

相關連結
	機構典藏計畫網站
	ROAR
	OpenDOAR
	SHERPA
	OAIster
	JAIRO
	Ira
	DSPACE
	RWWR
	臺大學術典藏NTU Scholars

"shao y y"的相關文件

回到依作者瀏覽
依題名排序	依日期排序

顯示項目 291-300 / 396 (共40頁)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
每頁顯示[10|25|50]項目

機構	日期	題名	作者
臺大學術典藏	2020-04-28T07:25:18Z	Integrated stable isotope labeling by amino acids in cell culture (SILAC) and isobaric tags for relative and absolute quantitation (iTRAQ) quantitative proteomic analysis identifies galectin-1 as a potential biomarker for predicting sorafenib resistance in liver cancer	Chow L.-P.; Feng W.-C.; Ho W.-C.; Tsai M.-H.; Shao Y.-Y.; CHIH-HUNG HSU; Yeh C.-C.; Yeh C.-C.;Chih-Hung Hsu;Shao Y.-Y.;Ho W.-C.;Tsai M.-H.;Feng W.-C.;Chow L.-P.
臺大學術典藏	2020-04-28T07:25:15Z	Modified CLIP with objective liver reserve assessment retains prognosis prediction for patients with advanced hepatocellular carcinoma	Shao Y.-Y.;Liu T.-H.;Lee Y.-H.;Chih-Hung Hsu;Cheng A.-L.; Shao Y.-Y.; Liu T.-H.; Lee Y.-H.; CHIH-HUNG HSU; Cheng A.-L.
臺大學術典藏	2020-04-28T07:25:14Z	National policies fostering hospice care increased hospice utilization and reduced the invasiveness of end-of-life care for cancer patients	Shao Y.-Y.;Hsiue E.H.-C.;Chih-Hung Hsu;Yao C.-A.;Chen H.-M.;Lai M.-S.;Cheng A.-L.; Shao Y.-Y.; Hsiue E.H.-C.; CHIH-HUNG HSU; Yao C.-A.; Chen H.-M.; Lai M.-S.; Cheng A.-L.
臺大學術典藏	2020-04-28T07:25:14Z	Prescription patterns of sorafenib and outcomes of patients with advanced hepatocellular carcinoma: A national population study	Lu L.-C.;Chen P.-J.;Yeh Y.-C.;Chih-Hung Hsu;Chen H.-M.;Lai M.-S.;Shao Y.-Y.;Cheng A.-L.; Lu L.-C.; Chen P.-J.; Yeh Y.-C.; CHIH-HUNG HSU; Chen H.-M.; Lai M.-S.; Shao Y.-Y.; Cheng A.-L.
臺大學術典藏	2020-04-28T07:25:13Z	High plasma interleukin-6 levels associated with poor prognosis of patients with advanced hepatocellular carcinoma	Shao Y.-Y.;Lin H.;Li Y.-S.;Lee Y.-H.;Chen H.-M.;Cheng A.-L.;Chih-Hung Hsu; Shao Y.-Y.; Lin H.; Li Y.-S.; Lee Y.-H.; Chen H.-M.; Cheng A.-L.; CHIH-HUNG HSU
臺大學術典藏	2020-04-28T07:25:13Z	Lenalidomide as second-line therapy for advanced hepatocellular carcinoma: exploration of biomarkers for treatment efficacy	Shao Y.-Y.; Shao Y.-Y.;Chen B.-B.;Ou D.-L.;Lin Z.-Z.;Chih-Hung Hsu;Wang M.-J.;Cheng A.-L.;Hsu C.; Chen B.-B.; Ou D.-L.; Lin Z.-Z.; CHIH-HUNG HSU; Wang M.-J.; Cheng A.-L.; Hsu C.
臺大學術典藏	2020-04-28T07:25:13Z	Right or left? Side selection for a totally implantable vascular access device: A randomised observational study	Shao Y.-Y.; Hsu M.-C.; Lin W.-Y.;Lin C.-P.;Chih-Hung Hsu;Lee Y.-H.;Lin Y.-T.;Hsu M.-C.;Shao Y.-Y.; Lin W.-Y.; Lin C.-P.; CHIH-HUNG HSU; Lee Y.-H.; Lin Y.-T.
臺大學術典藏	2020-04-28T07:25:11Z	Successful Hepatic Arterial Infusion of Chemotherapy in a Patient with Advanced Hepatocellular Carcinoma and Impending Liver Failure	Liu T.-H.; CHIH-HUNG HSU; Shao Y.-Y.; Liu T.-H.;Chih-Hung Hsu;Shao Y.-Y.
臺大學術典藏	2020-04-28T07:25:08Z	A Multicenter Phase II Study of Second-Line Axitinib for Patients with Advanced Hepatocellular Carcinoma Failing First-Line Sorafenib Monotherapy	Lin Z.-Z.;Chen B.-B.;Hung Y.-P.;Huang P.-H.;Shen Y.-C.;Shao Y.-Y.;Chih-Hung Hsu;Cheng A.-L.;Lee R.-C.;Chao Y.;Hsu C.; Lin Z.-Z.; Chen B.-B.; Hung Y.-P.; Huang P.-H.; Shen Y.-C.; Shao Y.-Y.; CHIH-HUNG HSU; Cheng A.-L.; Lee R.-C.; Chao Y.; Hsu C.
臺大學術典藏	2020-04-10T12:51:19Z	Phase II study of combining sorafenib with metronomic tegafur/uracil for advanced hepatocellular carcinoma	Hsu C.-H.;Shen Y.-C.;Lin Z.-Z.;Chen P.-J.;Shao Y.-Y.;Ding Y.-H.;Chiun Hsu;Cheng A.-L.; Hsu C.-H.; Shen Y.-C.; Lin Z.-Z.; Chen P.-J.; Shao Y.-Y.; Ding Y.-H.; Chiun Hsu; Cheng A.-L.

顯示項目 291-300 / 396 (共40頁)
<< < 25 26 27 28 29 30 31 32 33 34 > >>
每頁顯示[10|25|50]項目